Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Adane F. Wogu"'
Autor:
Sarah K. Wendel, Adane F. Wogu, Nichole E. Carlson, Laurel Beaty, Tellen D. Bennett, Kelly Bookman, David A. Mayer, Sean S. Michael, Kyle C. Molina, Jennifer L. Peers, Seth Russell, Richard D. Zane, Adit A. Ginde
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 5, Iss 1, Pp n/a-n/a (2024)
Abstract Objectives To evaluate whether subcutaneous neutralizing monoclonal antibody (mAb) treatment given in the emergency department (ED) setting was associated with reduced hospitalizations, mortality, and severity of disease when compared to non
Externí odkaz:
https://doaj.org/article/2ee2a76cab2c4689931484b0dc424f25
Autor:
David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since eme
Externí odkaz:
https://doaj.org/article/9243363dc9f34305a5f57b6c977b0775
Autor:
Alexander M. Kaizer, Hayley M. Belli, Zhongyang Ma, Andrew G. Nicklawsky, Samantha C. Roberts, Jessica Wild, Adane F. Wogu, Mengli Xiao, Roy T. Sabo
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Clinical trials are constantly evolving in the context of increasingly complex research questions and potentially limited resources. In this review article, we discuss the emergence of “adaptive” clinical trials that allow for the preplanned modi
Externí odkaz:
https://doaj.org/article/42a107b8420a476abc7cc829ec215812
Autor:
Matthew K. Wynia, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, Christopher B. Davis, Bethany M. Kwan, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey D. Steele, Heather R. Stocker, Adane F. Wogu, Richard D. Zane, Ronald J. Sokol, Adit A. Ginde
Publikováno v:
Chest. 163:1061-1070
Neutralizing monoclonal antibodies (mAbs) were authorized for the treatment of COVID-19 outpatients based on clinical trials completed early in the pandemic, which were underpowered for mortality and subgroup analyses. Real-world data studies are pro
Publikováno v:
Biometrics.
In survival data analysis, a competing risk is an event whose occurrence precludes or alters the chance of the occurrence of the primary event of interest. In large cohort studies with long-term follow-up, there are often competing risks. Further, if
Autor:
Rafal Pawlinski, Adane F. Wogu, Laila Elsherif, Neil M. Matsui, Nigel S. Key, Kenneth I. Ataga, David Wichlan, Jianwen Cai
Publikováno v:
Transfusion. 61:1694-1698
INTRODUCTION The contribution of coagulation activation to the pathogenesis of sickle cell disease (SCD) remains incompletely defined. We evaluated the efficacy and safety of rivaroxaban, an oral direct factor Xa inhibitor, in subjects with sickle ce
Autor:
Neil R Aggarwal, Laurel E Beaty, Tellen D Bennett, Nichole E Carlson, Christopher B Davis, Bethany M Kwan, David A Mayer, Toan C Ong, Seth Russell, Jeffrey Steele, Adane F Wogu, Matthew K Wynia, Richard D Zane, Adit A Ginde
Publikováno v:
J Infect Dis
medRxiv
medRxiv
Neutralizing monoclonal antibodies (mAbs) are authorized for early symptomatic COVID-19 patients. Whether mAbs are effective against the SARS-CoV-2 Delta variant, among vaccinated patients, or for prevention of mortality remains unknown.To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87111a410f8822f0002ec1b5d7c91792
https://europepmc.org/articles/PMC10205600/
https://europepmc.org/articles/PMC10205600/
Autor:
Matthew K. Wynia, Laurel E. Beaty, Tellen D. Bennett, Nichole E. Carlson, Christopher B. Davis, Bethany M. Kwan, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Heather R. Stocker, Adane F. Wogu, Richard D. Zane, Ronald J. Sokol, Adit A. Ginde
Publikováno v:
medRxiv
BackgroundNeutralizing monoclonal antibodies (mAbs) are authorized for early symptomatic COVID-19 patients. Whether mAbs are effective against the SARS-CoV-2 Delta variant, among vaccinated patients, or for prevention of mortality remains unknown.Obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c470ce2e99647a3abbb1970c1c0ea04a
https://doi.org/10.1101/2022.01.09.22268963
https://doi.org/10.1101/2022.01.09.22268963
Autor:
Alan L. Hinderliter, Kenneth I. Ataga, David Wichlan, Jennifer S. Pollock, Laila Elsherif, David R. Archer, Vimal K. Derebail, Melissa C. Caughey, David M. Pollock, Adane F. Wogu, Jianwen Cai, Poulami Maitra
Publikováno v:
American Journal of Hematology. 94
Autor:
Jianwen Cai, Micah J. Mooberry, Kenneth I. Ataga, Matthew F. Whelihan, Ming Y. Lim, Anton Ilich, Mark Piegore, Dougald M. Monroe, Kenneth G. Mann, Adane F. Wogu, Nigel S. Key
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 14(10)
Essentials Sickle cell disease is increasingly being recognized as a chronic hypercoagulable state. Thrombin generation is elevated in the whole blood, but not the plasma of sickle cell patients. Whole blood thrombin generation inversely correlates t